CMS Issues FAQs to Assist Medicare Providers
From the Medicare Learning Network:
COVID-19 Response: CMS Issues FAQs to Assist Medicare Providers
On March 6, CMS issued frequently asked questions and answers (FAQs) for health care providers regarding Medicare payment for laboratory tests and other services related to the 2019-Novel Coronavirus (COVID-19). The agency is receiving questions from providers and created this document to be transparent and share answers to some of the most common questions.Included in the FAQs is:
- Guidance on how to bill and receive payment for testing patients at risk of COVID-19.
- Details of Medicare’s payment policies for laboratory and diagnostic services, drugs, and vaccines under Medicare Part B, ambulance services, and other medical services delivered by physicians, hospitals, and facilities accepting government resources.
- Information on billing for telehealth or in-home provider services. Since 2019, the Trump Administration has expanded flexibilities for CMS to pay providers for virtual check-ins and other digital communications with patients, which will make it easier for sick patients to stay home and lower the risk of spreading the infection.
Below is an updated list of CMS’ actions to date:
- March 5: Issued a second Healthcare Common Procedure Coding System (HCPCS) code for certain COVID-19 laboratory tests, in addition to three fact sheets about coverage and benefits for medical services related to COVID-19 for CMS programs
- March 4: Issued a call to action to health care providers nationwide and offered important guidance to help State Survey Agencies and Accrediting Organizations prioritize their inspections of healthcare
- February 13: Issued a new HCPCS code for providers and laboratories to test patients for COVID-19
- February 6: Gave CLIA-certified laboratories information about how they can test for SARS-CoV-2
- February 6: Issued a memo to help the nation’s health care facilities take critical steps to prepare for COVID-19